PREPARATION OF MONOCLONAL ANTIBODIES FOR DETECTION OF RECOMBINANT FLAGELLIN C FROM PSEUDOMONAS AERUGINOSA

被引:0
|
作者
Zherebtsov, A. P. [1 ]
Yakovleva, I., V [2 ]
Gavrilova, N. F. [2 ]
Mikhailova, N. A. [1 ]
机构
[1] I Mechnikov Res Inst Vaccines & Sera, Lab Protect Antigens, Moscow, Russia
[2] I Mechnikov Res Inst Vaccines & Sera, Lab Therapeut Vaccines, Moscow, Russia
来源
INFEKTSIYA I IMMUNITET | 2024年 / 14卷 / 03期
关键词
P; aeruginosa; flagellin; recombinant FliC protein; monoclonal antibodies; mAb; hybridoma-producer;
D O I
10.15789/2220-7619-POM-16865
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
An important virulence factor in the pathogenesis of infections caused by Pseudomonas aeruginosa is flagellin: it serves as the main structural component of the bacterial flagellum and an acceptor for the TLR5 receptor of the innate immune system. Toll-like receptor 5 is able to bind bacterial flagellin and activate the anti-inflammatory transcription factor NF-kappa B kappa B through the adapter protein MyD88, which induces the production of anti-inflammatory cytokines. The inclusion of flagellin in recombinant proteins increased the ability to stimulate the production of antiinflammatory cytokines and activate antigen-presenting cells. A number of experiments have shown that the use of flagellin as a molecular adjuvant in vaccines increases the expression of CD80, CD83, CD86 and MHC II molecules on the surface of dendritic cells, and also leads to an increase in the secretion of IFN gamma gamma and alpha-defensins by dendritic and NK cells; T cell proliferation and activation of antigen-specific cytotoxic T lymphocytes, as well as increased induction of antigen-specific IgG and IgA antibodies. Due to the natural and acquired resistance of P. aeruginosa to antibiotics, the available choice of antipseudomonas drugs is decreasing, and therefore the problem of developing effective therapeutic drugs to protect against this infection is of high medical and social importance. For this purpose, it seems promising to study the immunobiological properties of P. aeruginosa flagellin as a possible vaccine component. Based on this, in the Laboratory of Protective Antigens of the I. Mechnikov Research Institute of Vaccines and Sera, recombinant flagellin C (FliC) of P. aeruginosa was obtained, and its immunogenicity and protective properties were proven. However, the question of standardizing methods for screening and monitoring the resulting recombinant FliC protein remains open. To solve this issue, hybridomas producing monoclonal antibodies (mAb) of a given specificity were obtained, the basic immunochemical properties of mAbs were studied, and the possibility of using them as reagents in constructing a test system for identifying and standardizing the recombinant FliC protein upon its production was assessed. Purpose of the work: to obtain monoclonal antibodies to the recombinant flagellin C protein of P. aeruginosa; ; to study their basic immunochemical properties and to evaluate the possibility of using the recombinant FliC protein for screening and control.
引用
收藏
页码:551 / 556
页数:6
相关论文
共 50 条
  • [1] Cloning, expression, purification, and characterization of recombinant flagellin isolated from Pseudomonas aeruginosa
    Goudarzi, Gholamreza
    Sattari, Morteza
    Roudkenar, Mehryar Habibi
    Montajabi-Niyat, Mehran
    Zavaran-Hosseini, Ahmad
    Mosavi-Hosseini, Kamran
    BIOTECHNOLOGY LETTERS, 2009, 31 (09) : 1353 - 1360
  • [2] Cloning, expression, purification, and characterization of recombinant flagellin isolated from Pseudomonas aeruginosa
    Gholamreza Goudarzi
    Morteza Sattari
    Mehryar Habibi Roudkenar
    Mehran Montajabi-Niyat
    Ahmad Zavaran-Hosseini
    Kamran Mosavi-Hosseini
    Biotechnology Letters, 2009, 31 : 1353 - 1360
  • [3] Preparation of Pseudomonas aeruginosa alginate-flagellin immunoconjugate
    Faezi, Sobhan
    Bahrmand, Ahmad Reza
    Mahdavi, Mehdi
    Siadat, Seyed Davar
    Sardari, Soroush
    Nikokar, Iraj
    Khanaki, Korosh
    Mirzajani, Ebrahim
    Goudarzi, Gholamreza
    BIOLOGICALS, 2017, 47 : 11 - 17
  • [4] PREPARATION, CHARACTERIZATION, AND USE OF MONOCLONAL-ANTIBODIES TO EXOTOXIN-A FROM PSEUDOMONAS-AERUGINOSA
    GALLOWAY, DR
    HEDSTROM, RC
    FALK, MC
    PAVLOVSKIS, OR
    FEDERATION PROCEEDINGS, 1983, 42 (07) : 1809 - 1809
  • [5] Pseudomonas aeruginosa infections are prevented in cystic fibrosis patients by avian antibodies binding Pseudomonas aeruginosa flagellin
    Nilsson, E.
    Amini, A.
    Wredind, B.
    Larsson, A.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2007, 856 (1-2): : 75 - 80
  • [6] Pseudomonas aeruginosa infections are prevented in cystic fibrosis patients by avian antibodies binding Pseudomonas aeruginosa flagellin
    Nilsson, E.
    Amini, A.
    Wretlind, B.
    Larsson, A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 : 83 - 83
  • [7] Monoclonal antibodies recognize conformational epitopes on wild-type and recombinant mutant amidases from Pseudomonas aeruginosa
    Martins, Sonia
    Lourenco, Sara
    Karmali, Amin
    Serralheiro, Maria Luisa
    MOLECULAR BIOTECHNOLOGY, 2007, 37 (02) : 136 - 145
  • [8] Monoclonal Antibodies Recognize Conformational Epitopes on Wild-type and Recombinant Mutant Amidases from Pseudomonas aeruginosa
    Sónia Martins
    Sara Lourenço
    Amin Karmali
    Maria Luísa Serralheiro
    Molecular Biotechnology, 2007, 37 : 136 - 145
  • [9] Preparation of Recombinant Atoxic Form of Exotoxin A from Pseudomonas Aeruginosa
    Kaloshin, A. A.
    Isakov, M. A.
    Mikhailova, N. A.
    Vertiev, Ju. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 154 (03) : 346 - 350
  • [10] Preparation of Recombinant Atoxic Form of Exotoxin A from Pseudomonas Aeruginosa
    A. A. Kaloshin
    M. A. Isakov
    N. A. Mikhailova
    Ju. V. Vertiev
    Bulletin of Experimental Biology and Medicine, 2013, 154 : 346 - 350